Vergleich

CCRF-CEM cells

ArtNr C0003001
Hersteller Addexbio
Menge One Frozen vial
Kategorie
Typ Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Adams, M., Efferth, T., and Bauer, R. Activity-guided isolation of scopoletin and isoscopoletin, the inhibitory active principles towards CCRF-CEM leukaemia cells and multi-drug resistant CEM/ADR5000 cells, from Artemisia argyi. Planta Med, 72: 862-864, 2006.
2.Anderson, A. B. and Arriaga, E. A. Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM/C2 cell lines after treatment with doxorubicin. J Chromatogr B Analyt Technol Biomed Life Sci, 808: 295-302, 2004.
3.Henrich, S., Crossett, B., and Christopherson, R. I. Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MEC-1 and Raji cells correlate with cellular properties. Proteomics Clin Appl, 1: 1252-1265, 2007.
4.Jow, G. M., Wu, Y. C., Guh, J. H., and Teng, C. M. Armepavine oxalate induces cell death on CCRF-CEM leukemia cell line through an apoptotic pathway. Life Sci, 75: 549-557, 2004.
5.Kong, Y., Ma, W., Liu, X., Zu, Y., Fu, Y., Wu, N., Liang, L., Yao, L., and Efferth, T. Cytotoxic activity of curcumin towards CCRF-CEM leukemia cells and its effect on DNA damage. Molecules, 14: 5328-5338, 2009.
6.Zu, Y., Liu, X., Fu, Y., Shi, X., Wu, N., Yao, L., and Efferth, T. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage. Planta Med, 75: 1134-1140, 2009.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Lieferbar
Description
Disease:
Acute lymphoblastic leukemia
Origin:
Lymphoblast
Species:
Homo sapiens
Tissue:
Blood
Morphology:
Lymphoblast
Properties:
Suspension
Cytogenic data:
CCRF-CEM cells were derived from the peripheral blood buffy coat of a child (CEM) with acute lymphoblastic leukemia who had originally presented with lymphosarcoma
Patient:
Female, Caucasian, 4 yrs of age
Medium:
RPMI1640 + 10% FBS
Subculture:
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 105 viable cells/ml. Maintain cell density between 1 to 2 X 106 viable cells/ml.
Medium Renewal:
Add fresh medium (20% to 30% by volume) every 2 to 3 days.
Freezing Medium:
Complete culture medium supplemented with 5% (v/v) DMSO
Biosafety Level: I
Sterility:
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
Pathogens:
HIV: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Isoenzymes: ADA, 1; ES-D, 1; G6PD, B ; GLO-I, 1; PEP-D, 1; PGD, C; PGM1, 1 ; PGM3, 0
DNA Profile (STR): Amelogenin: X ; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 10, 13; D5S818: 12, 13; D7S820: 9, 13; THO1: 6, 7; TPOX: 8; vWA: 17, 19
Related cells by Organ: CCRF-CEM K562
LP-1
MOLM-13
RPMI-8226
U937
RAW 264.7
Storage condition
LN2
Manufacturer - Category
Cell Lines

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: One Frozen vial
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 25.12.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen